期刊文献+

乳腺癌中VEGF-D及HER-2的表达与淋巴道转移的关系

Relationship between VEGF-D and HER-2 Expression and Lymphy Vessel Metastsis in Breast Cancer
下载PDF
导出
摘要 目的探讨乳腺癌中血管内皮生长因子D(vascular endothelial growth factor D,VEGF-D)及人表皮生长因子受体-2(human epidermal growth factor receptor2,HER-2)的表达及其与淋巴道转移的关系。方法采用免疫组化法检测80例乳腺癌组织中VEGF及HER-2的表达情况,并分析其与病人临床病理特征的关系。结果 VEGF-D阳性率在淋巴结转移组为84%(42/50),显著高于未淋巴结转移组36%(11/30)(P<0.01)。HER-2阳性率在淋巴结转移组为76%(38/50),显著高于未淋巴结转移组33.3%(10/30)(P<0.01)。VEGF-D和HER-2的表达显著相关(P<0.05)。VEGF-D的表达与年龄、肿瘤大小、组织学分级无关(P>0.05)。结论 VEGF-D和HER-2的表达与乳腺癌淋巴道转移有关,可能促进乳腺癌淋巴管的生成和增殖。 Objective To study the relationship between vascular endothelial growth factor D (VEGF-D) and human epidermal growth factor receptor 2 (HER-2) expression and lymphy vessel metastsis in breast cancer.Methods The VEGF-D and HER-2 expression was examined by immunohistochemistry in 80 patients with breast cancer.Results The positive rate of VEGF-D,84% (42/50) in lymph node metastasis group,was significantly higher than 36% (11/30) in the group without lymph node metastasis (P0.01).The positive rate of HER-2,76% (38/50) in lymph node metastasis group,was significantly higher than 33.3% (10/30) in the group without lymph node metastasis (P0.01).Significant correlation was found between the expression of VEGF-D and HER-2 (P0.05).There was no correlation between VEGF-D expression with age,tumor size and pathology grade (P0.05).Conclusion The expression of VEGF-D and HER-2 is correlated with lymph vessal metastasis and may promote lymph angiogenesis and proliferation in breast cancer.
出处 《华南国防医学杂志》 CAS 2010年第4期275-277,共3页 Military Medical Journal of South China
关键词 乳腺癌 血管内皮生长因子D 人表皮生长因子受体-2 淋巴道转移 Breast cancer Vascular endothelial growth factor D Human epidermal growth factor receptor 2 Lymph vessel metastasis
  • 相关文献

参考文献7

  • 1Partanen TA,Paavonen K.Lymphatic versus blood vascular endothelial growth factors and receptors in humans[J].Microsc Res Tech,2001,55(2):108-121.
  • 2Ray A,Sharma BK,Kaur S,et al.Overexpression of c-erbB-2 oncoprotein and associated pathobiological factors in invasive primary breast cancer[J].Indian J Exp Biol,2004,42(3):253-258.
  • 3Yonemura Y,Endo Y,Tabata K,et al.Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer[J].Int J Clin Oncol,2005,10(5):318-327.
  • 4Stacker SA,Caesar C,Baldwin ME,et al.VEGF-D Promotes the metastatic spread of tumor cells via the lymphatics[J].Nat Med,2001,7(2):186-191.
  • 5Nakamura Y,Yasuoka H,Tsujimoto M,et al.Prognostic Significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up[J].Clin Cancer Res,2003,9(2):716-721.
  • 6崔玉宝,陈斓.乳腺癌HER-2癌基因的表达及临床意义[J].医学理论与实践,2007,20(4):382-384. 被引量:1
  • 7Climent MA,Seguí MA,Peiró G,et al.Prognostic value of HER-2/neu and P53 expression in node-positive breast cancer HER-2/neu effect on adjuvant tamoxifen treatment[J].Breast,2001,10(1):67-77.

二级参考文献15

  • 1滕晓东.癌基因C-erbB-2在乳腺癌的表达及意义[J].中国肿瘤临床与康复,1997,4(1):28-29. 被引量:5
  • 2Singleton TP,Strickler JG.Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene[J].Pathol Annu,1992,27:165-190.
  • 3Shih C,Padhy LC,Murray M,et al.Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts[J].Nature,1981,290:261-264.
  • 4Semba K,Kamata N,Toyoshima K,et al.A v-erbB-related protooncogene,c-erbB-2,is distinct from the c-erb-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma[J].Proc Natl Acad USA,1985,82:6497-6501.
  • 5Coussens L,Yang-Feng TL,Liao TC,et al.Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene[J].Science,1985,230:1132-1139.
  • 6Schechter AL,Hung M-C,Vaidyanathan L,et al.The neu gene:an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor[J].Science,1985,229:976-978.
  • 7Schechter AL,Stern DF,Vaidyanathan L,et al.The new oncogene:an erb-B-related gene encoding a 185000-Mr tumor antigen[J].Nature,1984,312(5994):513.
  • 8Sakamoto G,Mitsuyama S.New molecule-targeting therapy with herceptin(trastuzumab),an Anti-HER-2(C-erbB-2) monoclonal antibody[J].Breast Cancer,2000,7:350-357.
  • 9Dean CJ,Eccles SA,Valeri M,et al.Rat Mabs to the product of the C-erbB-2 proto-oncogene for diagnosis and therapy in breast cancer[J].Cell Biophys,1993,22:111-127.
  • 10Gottfried K,Giovanni P,Mark P,et al.Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer[J].J Natl Cancer Ins,2003,95:142-153.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部